PTPI: Petros Pharmaceuticals, Inc. Stock

by  •  • Comments Off on PTPI: Petros Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 2.65
Enterprise Value ($M) 6.01
Book Value ($M) 3.12
Book Value / Share 0.31
Price / Book 0.85
NCAV ($M) -6.85
NCAV / Share -0.68
Price / NCAV -0.39

Profitability (mra)
Return on Invested Capital (ROIC) -0.45
Return on Assets (ROA) -0.14
Return on Equity (ROE) -0.38

Liquidity (mrq)
Quick Ratio 0.61
Current Ratio 0.85

Balance Sheet (mrq) ($M)
Current Assets 10.72
Assets 20.69
Liabilities 17.58
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-14 13G/A Ayrton Capital LLC 6.50 175.45
11-13 13G/A Intracoastal Capital, Llc 4.99 226.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2024-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2024-05-31 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1)
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2024-04-01 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-04 42,345 95,934 44.14
2025-02-03 27,029 177,574 15.22
2025-01-31 100,002 428,951 23.31
2025-01-30 65,717 180,339 36.44

(click for more detail)

Similar Companies
PRQR – ProQR Therapeutics N.V. PRTG – Portage Biotech Inc.
PTIX – Protagenic Therapeutics, Inc. PULM – Pulmatrix, Inc.
QLGN – Qualigen Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io